Xiaohai Wang

发表

Detecting tau in serum of transgenic animal models after tau immunotherapy treatment

P. Davies, C. d’Abramo, G. Terracina, 2016, Neurobiology of Aging.

fMRI study of the role of glutamate NMDA receptor in the olfactory processing in monkeys

J. Uslaner, J. Evelhoch, C. Hines, 2018, PloS one.

Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology

Lynn A. Hyde, J. Melchor, J. Hess, 2015, Molecular Neurodegeneration.

A novel link between clusterin and tau pathology in Alzheimer's disease

J. Renger, Katherine Tugusheva, K. Tanis, 2013, Alzheimer's & Dementia.

Pharmacological Characterization of the Novel and Selective α7 Nicotinic Acetylcholine Receptor–Positive Allosteric Modulator BNC375

J. Uslaner, F. Thomson, A. Harvey, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Activators of α7 nAChR as Potential Therapeutics for Cognitive Impairment.

J. Uslaner, Xiaohai Wang, I. M. Bell, 2020, Current topics in behavioral neurosciences.

Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice

N. Hastings, B. Butts, R. Hargreaves, 2017, Molecular Neurodegeneration.

fMRI study of olfaction in the olfactory bulb and high olfactory structures of rats: Insight into their roles in habituation

Fuqiang Zhao, Donald S. Williams, Xiaohai Wang, 2016, NeuroImage.

Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition

Steven V. Fox, Xiaohai Wang, Jason M. Uslaner, 2013, Science Translational Medicine.

The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model

J. Uslaner, S. Kuduk, Joshua D. Vardigan, 2015, Behavioural Brain Research.

Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology

Lynn A. Hyde, J. Melchor, J. Hess, 2015, Molecular Neurodegeneration.

scRNA-seq generates a molecular map of emerging cell subtypes after sciatic nerve injury in rats

J. Uslaner, Ditte Lovatt, Alex M. Tamburino, 2022, Communications Biology.

MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy

Lynn A. Hyde, E. Hostetler, J. Uslaner, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy

J. Uslaner, Sean M. Smith, J. Hess, 2018, PloS one.

Discovery of MK-8719, A Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies.

D. Klein, J. Hess, D. Vocadlo, 2019, Journal of medicinal chemistry.

Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice

Lynn A. Hyde, N. Hastings, B. Butts, 2017, Molecular Neurodegeneration.

fMRI study of the role of glutamate NMDA receptor in the olfactory adaptation in rats: Insights into cellular and molecular mechanisms of olfactory adaptation

Fuqiang Zhao, Xiaohai Wang, Hatim A. Zariwala, 2017, NeuroImage.

fMRI study of olfaction in the olfactory bulb and high olfactory structures of rats: Insight into their roles in habituation

Hatim A. Zariwala, Donald S. Williams, J. Uslaner, 2016, NeuroImage.

EARLY CLINICAL RESULTS AND PRECLINICAL VALIDATION OF THE O-GLCNACASE (OGA) INHIBITOR MK-8719 AS A NOVEL THERAPEUTIC FOR THE TREATMENT OF TAUOPATHIES

Dawn M. Toolan, Joseph James Duffy, J. Renger, 2016, Alzheimer's & Dementia.